Steven Klein

Steven Klein

Auto-generated profile, based on publicly available information

Steven Klein

Division of Human Genetics and the Center for Childhood Cancer Research, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2013 in Autism Research
Verified
Journal Article
Closed access
PDF file
SKSteven Klein
Steven Klein
PSPantea Sharifi‐Hannauer
Pantea Sharifi‐Hannauer
JMJulian Martinez-Agosto
Julian Martinez-Agosto

27 March 2014 in Journal of Medical Genetics
Verified
Journal Article
Closed access
PDF file
SKSteven Klein
Steven Klein
HLHane Lee
Hane Lee
SGShahnaz Ghahremani
Shahnaz Ghahremani
PKPamela Kempert
Pamela Kempert
MIMariam Ischander
Mariam Ischander
JMJulian Martinez-Agosto
Julian Martinez-Agosto
Background Constitutional DICER1 mutations have been associated with pleuropulmonary blastoma, cystic nephroma, Sertoli-Leydig tumours and multinodular goitres, while somatic DICER1 mutations have been reported in additional tumour types. Here we report a novel syndrome termed GLOW, an acronym for its core phenotypic findings, which include Global developmental delay, Lung cysts, Overgrowth and Wilms tumour caused by mutations in the RNase IIIb domain of DICER1. Methods and results We performed whole exome sequencing on peripheral mononuclear blood cells of an affected proband and identified a de novo missense mutation in the RNase IIIb domain of DICER1. We confirmed an additional de novo missense mutation in the same domain of an unrelated case by Sanger sequencing. These missense mutations in the RNase IIIb domain of DICER1 are suspected to affect one of four metal binding sites located within this domain. Pyrosequencing was used to determine the relative abundance of mutant alleles in various tissue types. The relative mutation abundance is highest in Wilms tumour and unaffected kidney samples when compared with blood, confirming that the mutation is mosaic. Finally, we performed bioinformatic analysis of microRNAs expressed in murine cells carrying specific Dicer1 RNase IIIb domain metal binding site-associated mutations. We have identified a subset of 3p microRNAs that are overexpressed whose target genes are over-represented in mTOR, MAPK and TGF-β signalling pathways. Conclusions We propose that mutations affecting the metal binding sites of the DICER1 RNase IIIb domain alter the balance of 3p and 5p microRNAs leading to deregulation of these growth signalling pathways, causing a novel human overgrowth syndrome.

11 March 2017 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
SMSureni V. Mullegama
Sureni V. Mullegama
SKSteven D. Klein
Steven D. Klein
MMMilene V. Mulatinho
Milene V. Mulatinho
TSTharanga Niroshini Senaratne
Tharanga Niroshini Senaratne
KSKathryn Singh
Kathryn Singh
JMJulian Martinez-Agosto
Julian Martinez-Agosto

15 November 2016 in Scientific Reports
Verified
Journal Article
Open access
MBMatthew S. Bramble
Matthew S. Bramble
LRLara Roach
Lara Roach
ALAllen Lipson
Allen Lipson
NVNeerja Vashist
Neerja Vashist
AEAscia Eskin
Ascia Eskin
EVEric Vilain
Eric Vilain
The mechanisms by which sex differences in the mammalian brain arise are poorly understood, but are influenced by a combination of underlying genetic differences and gonadal hormone exposure. Using a mouse embryonic neural stem cell (eNSC) model to understand early events contributing to sexually dimorphic brain development, we identified novel interactions between chromosomal sex and hormonal exposure that are instrumental to early brain sex differences. RNA-sequencing identified 103 transcripts that were differentially expressed between XX and XY eNSCs at baseline (FDR = 0.10). Treatment with testosterone-propionate (TP) reveals sex-specific gene expression changes, causing 2854 and 792 transcripts to become differentially expressed on XX and XY genetic backgrounds respectively. Within the TP responsive transcripts, there was enrichment for genes which function as epigenetic regulators that affect both histone modifications and DNA methylation patterning. We observed that TP caused a global decrease in 5-methylcytosine abundance in both sexes, a transmissible effect that was maintained in cellular progeny. Additionally, we determined that TP was associated with residue-specific alterations in acetylation of histone tails. These findings highlight an unknown component of androgen action on cells within the developmental CNS, and contribute to a novel mechanism of action by which early hormonal organization is initiated and maintained.

25 September 2024 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
JKJennifer M. Kalish
Jennifer M. Kalish
KBKerri D. Becktell
Kerri D. Becktell
GBGaëlle Bougeard
Gaëlle Bougeard
GBGarrett M. Brodeur
Garrett M. Brodeur
LDLisa Diller
Lisa Diller
JBJack Brzezinski
Jack Brzezinski
Wilms tumors are commonly associated with predisposition syndromes, many but not all of which include overgrowth. Several of these syndromes also include a risk of other embryonal malignancies—particularly hepatoblastoma. Guidelines for surveillance in this population were published in 2017, and recently, members of the American Association for Cancer Research Pediatric Cancer Working Group met to update those guidelines with a review of more recently published evidence and risk estimates. This perspective serves to update pediatric oncologists, geneticists, radiologists, counselors, and other health care professionals on revised diagnostic criteria; review previously published surveillance guidelines; and harmonize updated surveillance recommendations in the North American and Australian contexts for patients with overgrowth syndromes and other syndromes associated with Wilms tumor predisposition.

16 November 2018 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
PDF file
SMSureni V. Mullegama
Sureni V. Mullegama
SKSteven D. Klein
Steven D. Klein
RSRebecca H. Signer
Rebecca H. Signer
UCUcla Clinical Genomics Center
Ucla Clinical Genomics Center
EVEric Vilain
Eric Vilain
JMJulian Martinez-Agosto
Julian Martinez-Agosto
Background: The cohesin complex is a multi‐subunit protein complex which regulates sister chromatid cohesion and separation during cellular division. In addition, this evolutionarily conserved protein complex plays an integral role in DNA replication, DNA repair, and the regulation of transcription. The core complex is composed of four subunits: RAD21, SMC1A, SMC3, and STAG1/2. Mutations in these proteins have been implicated in human developmental disorders collectively termed “cohesinopathies.”Methods: Using clinical exome sequencing, we have previously identified three female cases with heterozygous STAG2 mutations and overlapping syndromic phenotypes. Subsequently, a familial missense variant was identified in five male family members.Results: We now present the case of a 4‐year‐old male with developmental delay, failure to thrive, short stature, and polydactyly with a likely pathogenic STAG2 de novo missense hemizygous variant, c.3027A>T, p.Lys1009Asn. Furthermore, we compare the phenotypes of the four previously reported STAG2 variants with our case.Conclusion: We conclude that mutations in STAG2 cause a novel constellation of sex‐specific cohesinopathy‐related phenotypes and are furthermore, essential for neurodevelopment, human growth, and behavioral development.